These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10430835)

  • 21. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).
    de Leon MJ; Convit A; Wolf OT; Tarshish CY; DeSanti S; Rusinek H; Tsui W; Kandil E; Scherer AJ; Roche A; Imossi A; Thorn E; Bobinski M; Caraos C; Lesbre P; Schlyer D; Poirier J; Reisberg B; Fowler J
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10966-71. PubMed ID: 11526211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired Integrity of Parahippocampal Cingulum Fibers.
    Fischer FU; Wolf D; Fellgiebel A;
    J Alzheimers Dis; 2017; 60(4):1285-1294. PubMed ID: 29036815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography.
    Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T
    Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.
    Didic M; Felician O; Gour N; Bernard R; Pécheux C; Mundler O; Ceccaldi M; Guedj E
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1512-21. PubMed ID: 25900275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance in recognition memory is correlated with entorhinal/perirhinal interictal metabolism in temporal lobe epilepsy.
    Guedj E; Barbeau EJ; Liégeois-Chauvel C; Confort-Gouny S; Bartolomei F; Chauvel P; Cozzone PJ; Ranjeva JP; Mundler O; Guye M
    Epilepsy Behav; 2010 Dec; 19(4):612-7. PubMed ID: 21035404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
    Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.
    Minoshima S; Cross DJ; Foster NL; Henry TR; Kuhl DE
    Ann N Y Acad Sci; 1999; 893():350-2. PubMed ID: 10672264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional neuroanatomical associations of working memory in early-onset Alzheimer's disease.
    Kobylecki C; Haense C; Harris JM; Stopford CL; Segobin SH; Jones M; Richardson AMT; Gerhard A; Anton-Rodriguez J; Thompson JC; Herholz K; Snowden JS
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):176-184. PubMed ID: 28299814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.